+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Is diagnosing cardio-facio-cutaneous (CFC) syndrome still a challenge? Delineation of the phenotype in 15 Polish patients with proven mutations, including novel mutations in the BRAF1 gene

Is diagnosing cardio-facio-cutaneous (CFC) syndrome still a challenge? Delineation of the phenotype in 15 Polish patients with proven mutations, including novel mutations in the BRAF1 gene

European Journal of Medical Genetics 58(1): 14-20

Cardio-facio-cutaneous (CFC) syndrome is characterized by a variable degree of developmental delay and congenital anomalies, including characteristic facial, cardiac, and ectodermal abnormalities. It is caused by activating mutations in the Ras/mitogen-activated protein kinase (MAPK) signaling pathway. In, however, approximately 10%-30% of individuals with a clinical diagnosis of CFCS, no mutation of the causative gene is found. Therefore, clinical studies in patients with the CFCS spectrum are valuable. To investigate the phenotypic spectrum and molecular diversity of germline mutations affecting genes encoding serine/threonine kinases, a group of 15 children and young adults with a diagnosis of CFCS was screened. We documented three novel mutations in the BRAF gene and correlated clinical findings with causative mutations in the BRAF or MEK1/MEK2 genes.

(PDF emailed within 0-6 h: $19.90)

Accession: 058167860

Download citation: RISBibTeXText

PMID: 25463315

DOI: 10.1016/j.ejmg.2014.11.002

Related references

Further delineation of cardio-facio-cutaneous syndrome: clinical features of 38 individuals with proven mutations. Journal of Medical Genetics 45(4): 249-254, 2007

Further delineation of the phenotype resulting from BRAF or MEK1 germline mutations helps differentiate cardio-facio-cutaneous syndrome from Costello syndrome. American Journal of Medical Genetics. Part A 143a(13): 1472-1480, 2007

Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome. European Journal of Human Genetics 11(2): 201-206, February, 2003

Distinguishing Costello versus cardio-facio-cutaneous syndrome: BRAF mutations in patients with a Costello phenotype. American Journal of Medical Genetics. Part A 140(15): 1681-1683, 2006

Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome. Journal of Medical Genetics 44(12): 763-771, 2007

Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nature Genetics 38(3): 294-296, 2006

Biochemical characterization of novel germline BRAF and MEK mutations in cardio-facio-cutaneous syndrome. Methods in Enzymology 438: 277-289, 2008

Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science 311(5765): 1287-1290, 2006

Cardio-facio-cutaneous (CFC) syndrome: A distinct entity? Report of three patients demonstrating the diagnostic difficulties in delineation of CFC syndrome. Clinical Genetics 52(1): 37-46, 1997

Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options. Human Molecular Genetics 17(3): 419-430, 2007

Cardio-facio-cutaneous syndrome: phenotypic variability and differential diagnosis in 3 cases with de novo BRAF mutations. Neuropediatrics 41(3): 127-131, 2011

New multiple congenital anomalies mental retardation syndrome with cardio facio cutaneous involvement the cardio facio cutaneous syndrome. American Journal of Medical Genetics 25(3): 413-428, 1986

Novel mutations in BCOR in three patients with oculo-facio-cardio-dental syndrome, but none in Lenz microphthalmia syndrome. European Journal of Human Genetics 13(5): 563-569, 2005

Cardio-facio-cutaneous syndrome phenotype and del(12q). American Journal of Medical Genetics. Part A 116a(4): 411-412, 2003

Exclusion of PTPN11 mutations in Costello syndrome: Further evidence for distinct genetic etiologies for Noonan, cardio-facio-cutaneous and Costello syndromes. Clinical Genetics 63(5): 423-426, 2003